American Regent Announces Launch, Availability of Selenious Acid Injection, USP

American Regent has announced the introduction of Selenious Acid Injection, USP.

"We are pleased to offer the first FDA approved Selenious Acid Injection - developed to reflect the American Society for Parenteral and Enteral Nutrition (ASPEN) recommendations for trace element supplementation.1 This approval underscores our commitment to the parenteral nutrition market in the long term," stated Harsher Singh, Chief Commercial and Strategic Officer at American Regent, Inc. In addition, the newly approved product will permit delivery of the recommended dose of Selenium in a smaller volume than the previously available marketed unapproved product.

Selenious Acid Injection is indicated in adult and pediatric patients as a source of selenium for parenteral nutrition (PN) when oral or enteral nutrition is not possible, insufficient, or contraindicated. Selenious Acid Injection is supplied as a pharmacy bulk package for admixing use only. It is not for direct intravenous infusion.

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content, 

please email: Julia.Zhang@ubmsinoexpo.com